文献速递肺外科

未切除与切除的小型肺类癌肿瘤的预后比较

Prognosis of Unresected vs Resected Small Pulmonary Carcinoid Tumors.
PubMed 文献 · Ann Thorac Surg · 2023-04-11

基于美国国家癌症数据库2004至2017年数据,纳入8435例小型(<3 cm)原发性肺类癌患者,其中783例(9.3%)观察、7652例(91%)接受手术切除。倾向性评分匹配后,手术切除与5年总生存改善相关(66% vs 81%,P < .001)。楔形切除与解剖性切除生存无显著差异(88% vs 88%,P = .83)。

要点

  • 小型肺类癌手术切除较观察改善5年总生存(66% vs 81%,P < .001)。
  • 楔形切除与解剖性切除5年总生存无显著差异(88% vs 88%,P = .83)。
  • 楔形切除时淋巴结采样提高5年总生存(90% vs 86%,P = .0042);解剖性切除时亦提高(88% vs 82%,P = .04)。

核心结论

  • 小型肺类癌手术切除与观察相比与生存改善相关。
  • 手术切除时,楔形切除与解剖性切除生存相似,淋巴结采样改善生存。

研究设计与样本

  • 查询美国国家癌症数据库,识别2004年至2017年间原发性肺类癌患者。
  • 纳入小型(<3 cm)原发性肺类癌、接受观察或肺切除的患者。
  • 使用倾向性评分匹配以减少指征混杂,匹配因素包括年龄、性别、种族、保险类型、Charlson-Deyo合并症评分、典型与非典型组织学、肿瘤大小和诊断年份。
  • 采用Kaplan-Meier生存分析比较匹配队列的5年总生存。

主要发现

  • 8435例小型肺类癌患者中,783例(9.3%)接受观察,7652例(91%)接受手术切除。
  • 倾向性评分匹配后,手术切除与5年总生存改善相关(66% vs 81%,P < .001)。
  • 楔形切除与解剖性切除的5年总生存无显著差异(88% vs 88%,P = .83)。
  • 接受切除的患者中,楔形切除时淋巴结采样提高5年总生存(90% vs 86%,P = .0042)。
  • 接受切除的患者中,解剖性切除时淋巴结采样提高5年总生存(88% vs 82%,P = .04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have shown that overall survival after lung resection for pulmonary carcinoid tumors is favorable. It is unclear what the prognosis is for observation rather than resection for small carcinoid tumors. METHODS: We queried the National Cancer Database to identify patients presenting with primary pulmonary carcinoid tumors between 2004 and 2017. We included patients with small (<3 cm) primary pulmonary carcinoids, who were observed or underwent a lung resection. To minimize confounding by indication, we used propensity score matching, while accounting for age, sex, race, insurance type, Charlson-Deyo comorbidity score, typical and atypical histology, tumor size, and year of diagnosis. We used Kaplan-Meier survival analyses to compare 5-year overall survival in the matched cohorts. RESULTS: Of 8435 patients with small pulmonary carcinoids, 783 (9.3%) underwent observation and 7652 (91%) underwent surgical resection. After propensity score matching, surgical resection was associated with improved 5-year overall survival (66% vs 81%, P < .001). No significant difference in overall survival was found between wedge and anatomic resection (88% vs 88%, P = .83). In patients undergoing resection, lymph node sampling at the time of wedge and anatomic resection increased 5-year overall survival (90% vs 86%, P = .0042; 88% vs 82%, P = .04, respectively). CONCLUSIONS: Surgical resection of small pulmonary carcinoids is associated with improved survival compared with observation. When surgical resection is performed, wedge and anatomic resection result in similar survival, and lymph node sampling improves survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Roat-Shumway S, Tonelli CM, Baker MS, et al. Prognosis of Unresected vs Resected Small Pulmonary Carcinoid Tumors. Ann Thorac Surg. 2023. PMID: 37054928. doi:10.1016/j.athoracsur.2023.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。